Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 31.1B | 30.0B | 31.7B | 31.4B |
| Cost of revenue | 20.0B | 20.1B | 20.6B | 20.4B |
| Gross profit | 11.1B | 10.0B | 11.2B | 11.0B |
| Operating expense | ||||
| Research & development | 864.8M | 883.5M | 865.9M | 863.5M |
| Selling general and admin | 3.8B | 3.7B | 3.7B | 3.7B |
| Other operating expenses | — | — | — | — |
| Operating income | 6.4B | 5.4B | 6.6B | 6.5B |
| Non operating interest income | ||||
| Income | 1.2B | 1.2B | 1.3B | 1.3B |
| Expense | 672.5M | 705.8M | 751.1M | 696.1M |
| Other income expense | — | — | — | — |
| Pretax income | 7.2B | 6.2B | 7.2B | 7.4B |
| Tax provision | 1.6B | 2.5B | 1.5B | 1.9B |
| Net income | 5.6B | 3.7B | 5.7B | 5.5B |
| Basic EPS | 10.8 | — | 11.0 | 10.9 |
| Diluted EPS | 10.8 | — | 11 | 10.7 |
| Basic average shares | 513.4M | — | 513.1M | 500.1M |
| Diluted average shares | 514.4M | — | 513.6M | 511.9M |
| EBITDA | 10.1B | 9.5B | 10.3B | 10.5B |
| Net income from continuing op. | 7.2B | 6.2B | 7.2B | 7.4B |
| Minority interests | -33.4M | -41.8M | -34.1M | -33.5M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |